Acetamidobenzamide compounds for neurodegenerative disorders
AssigneeCentaur Pharmaceuticals, Inc.
InventorsWilliam Flitter, William Garland, Richard Paylor, Allan Wilcox
Life of this patent
Estimating the term…
Abstract
A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.
Claims8
N-tert-butyl-4-acetamidobenzamide.
A pharmaceutical composition comprising a pharmaceutically inert carrier and a pharmaceutically effective amount of N-tert-butyl-4-acetamidobenzamide.
Dependencies are inferred from the claim text.